The present invention relates to an antioxidant and lutein supplement composition which inter alia decreases visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in people with early age-related macular degeneration.

 
Web www.patentalert.com

< Binding compounds specific for cysteine-rich soluble protein C23

> IMPROVEMENTS IN RELATION TO CANCER THERAPY

> Gamma-butyrolactone compound and pharmaceutical composition thereof
~ 00576